Of note, BRG1 is significantly overexpressed in some human cancer types including breast cancer, medullablastoma, and acute leukemia, where BRG1 is found to be essential for promoting tumor cell proliferation and clinically high expression of BRG1 is usually correlated with poor outcome (192–194). This evidence concerns the gene SMARCA4 and breast carcinoma.